Pharmaron US Competitors and Similar CompaniesClear all

Pharmaron US's competitors and similar companies include Proteome Sciences, Source Bioscience, Avacta Group and Stemina Biomarker Discovery.
Pharmaron US
Pharmaron US
Pharmaron US is a provider of bioanalysis testing services.
Proteome Sciences
Proteome Sciences
Reaching New Heights in Biomarker Solutions-Protein and peptide biomarker solutions for pharmaceutical and diagnostics applications
Source Bioscience
Source Bioscience
Source BioScience is an international genetic analysis and diagnostics company serving the healthcare and life science research markets.
Avacta Group
Avacta Group
Avacta Group plc is a provider of technologies, consumables and reagents for the life science markets, from drug discovery to diagnostics
Stemina Biomarker Discovery
Stemina Biomarker Discovery
Stemina Biomarker Discovery is a metabolomics company focused on the discovery, development, and commercialization of molecular biomarkers.
Founding Date
Founding Date
2006
Founding Date
N/A
Founding Date
N/A
Founding Date
2003
Founding Date
2006
Type
Type
Private
Type
Public
Type
Private
Type
Public
Type
Private
Tags
Locations
Locations
Louisville, US HQ
Locations
Addlestone, GB HQ
Frankfurt Am Main, DE
Cobham, GB
Locations
Nottingham, GB HQ
Dublin 9, IE
Tramore, IE
Cambridge, GB
Kingsway Business Park, GB
San Diego, US
Locations
Wetherby, GB HQ
London, GB
Whittlesford, GB
Locations
HQ
Employees
Employees
18,600
Employees
363% increase
Employees
2043% increase
Employees
154
Employees
11
Valuation ($)
Valuation ($)
N/A
Valuation ($)
10.5 m
Valuation ($)
N/A
Valuation ($)
264.5 m
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
£3.8m (FY, 2025)
Revenue (est.)
£13.6m (FY, 2017)
Revenue (est.)
£24.4m (FY, 2024)
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
£2.9m (FY, 2025)
Cost of goods
£8.2m (FY, 2017)
Cost of goods
£13.1m (FY, 2024)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
£845k (FY, 2025)
Gross profit
£5.4m (FY, 2017)
Gross profit
£11.3m (FY, 2024)
Gross profit
N/A
Net income
Net income
N/A
Net income
(£3.1m) (FY, 2025)
Net income
(£5.3m) (FY, 2017)
Net income
(£30.4m) (FY, 2024)
Net income
N/A
For sources of this data, please see the company profile

View Company Profiles

Proteome Sciences
HQ
Addlestone, GB
Employees
36↑ 3% increase

Reaching New Heights in Biomarker Solutions-Protein and peptide biomarker solutions for pharmaceutical and diagnostics applications

View company
Source Bioscience
HQ
Nottingham, GB
Employees
204↑ 3% increase

Source BioScience is an international genetic analysis and diagnostics company serving the healthcare and life science research markets.

View company
Avacta Group
HQ
Wetherby, GB
Employees
154

Avacta Group plc is a provider of technologies, consumables and reagents for the life science markets, from drug discovery to diagnostics

View company
Stemina Biomarker Discovery
HQ
Employees
11

Stemina Biomarker Discovery is a metabolomics company focused on the discovery, development, and commercialization of molecular biomarkers.

View company